Exome sequencing identifies a novel intronic mutation in ENG that causes recurrence of pulmonary arteriovenous malformations
Introduction
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler–Weber–Rendu disease, is an autosomal dominantly inherited vascular disease. Salient clinical features include the presence of mucocutaneous telangiectasia and arteriovenous malformations (AVM) in visceral organs, primarily the lungs, brain and liver. Early treatment of pulmonary arteriovenous malformations (PAVM), through which paradoxical brain embolism mediates, would ameliorate prognosis for a patient with HHT. Combination of accurate diagnosis by genetic testing, early treatment of PAVM, and careful clinical follow-up is crucial for HHT patients. However, even with early treatment, recurrence of pulmonary arteriovenous malformations has been reported after successful surgical removal or embolization treatment [1]. To date, four genes have been identified, ENG (HHT1), ACVRL1 (HHT2), SMAD4 and GDF2 (HHT5). It has been demonstrated that HHT is caused by either mutations in these genes or other genes that modulate transforming growth factor-beta (TGF-β) signaling (e.g., bone morphogenetic proteins). Two loci have been reported by linkage studies in familial cases, HHT3 and HHT4 on the region of 5q31.3-q32 and 7p14, respectively, in which the causative genes remain unknown [2]. Elucidation of genetic mechanisms would further contribute to better understanding the molecular pathogenicity of vasculopathy and developing new therapeutic strategies in HHT. We present here a family with a novel intronic mutation in ENG, and demonstrate further evidence of allelic heterogeneity in ENG-HHT1.
Section snippets
Ethics statement
The study was approved by the ethical review boards of the Kawasaki Medical Hospital and Tokushima University Hospital. All of the participants in this study gave written informed consent.
Subjects
The pedigree chart is illustrated in Fig. 1. There were three family members with a history of spontaneous and repeated epistaxis including the proband (Fig. 1: II-1, III-1 and III-2). Other members in this family presented as normal. All the living family members were examined by three experienced
Clinical features
The proband, a 61-year-old man, suddenly developed behavioral disorders and referred to the emergency unit in Kawasaki Medical Hospital. Physical examination demonstrated multiple telangiectasias on his lips, tongue, fingers, and earlobes (Fig. 1-B). Epistaxis from telangiectasias of the nasal mucosa was confirmed by flexible fiberscopic examination (Fig. 1-C). He had a history of repeated nasal bleeding since his late twenties. ESS-HTT of 1.92, categorized as mild, was given at admission.
Discussion
To date, more than 27 ENG mutations have been reported in hereditary hemorrhagic telangiectasia (HHT), including nonsense, missense, frame shift, deletion and splicing mutations [3], [5], [6]. Haploinsufficiency is presumably a cardinal pathomechanism in HHT caused by mutant ENG. Missense mutant ENG proteins dimerize with themselves, as well as with wild-type ENG proteins, and localize in the rough endoplasmic reticulum (rER) or in the plasma membrane of the cells. When the mutant ENG proteins
Author contribution
Naoki Saji and Takahiro Sato: patient review and medical writing for content. Toshitaka Kawarai: genetic testing, sequencing of mutation, and manuscript preparation. Ryosuke Miyamoto, Hiroyuki Morino and Ryosuke Oki: genetic testing and bioinformatic analysis. Antonio Orlacchio, Kazumi Kimura and Ryuji Kaji: study supervision and coordination.
Conflict of interest
The authors report no conflicts of interest.
Acknowledgements
This work was supported by Grants-in-Aid from the Research Committee of CNS Degenerative Diseases of the Ministry of Health, Labour and Welfare of Japan (R.K.), the Japan Society for the Promotion of Science (JSPS KAKENHI Grant no. 26870765 to N.S. and no. 26461294 to T.K.), the Brain Science Foundation, Japan (Grant to T.K.), and Grant-in-Aid for Research on rare and intractable diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis from the
References (17)
- et al.
Recurrence of pulmonary arteriovenous malformations in a female with hereditary hemorrhagic telangiectasia
Am J Med Sci
(2004) - et al.
Hereditary hemorrhagic telangiectasia
Rev Med Interne
(2014) - et al.
Exome sequencing reveals a novel MRE11 mutation in a patient with progressive myoclonic ataxia
J Neurol Sci
(2014) - et al.
Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia
Am J Hum Genet
(1997) - et al.
Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber syndrome)
Am J Med Genet
(2000) - et al.
Hereditary hemorrhagic telangiectasia in Japanese patients
J Hum Genet
(2014) - et al.
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information
Nucleic Acids Res
(1981) - et al.
Benign hereditary chorea: clinical, genetic, and pathological findings
Ann Neurol
(2003)
Cited by (0)
- 1
The first three authors contributed equally to this work.
- 2
The two corresponding authors contributed equally to this work.